MedTrace Logo

Thrombin in Cardiac Surgery

NCT04762576 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-11-09

No results posted yet for this study

Summary

Coagulopathy, bleeding, and transfusion are common in cardiac surgical patients. Our collaborator has developed a novel point of care device that can be used to assess thrombin generation in real-time in cardiac surgical patients. The investigators will measure thrombin generation using our novel device and compare it to standard methods, while examining the association of thrombin parameters with bleeding and other clinical outcomes.

Conditions

  • Thrombin
  • Hemostatic Disorder
  • Surgical Blood Loss
  • Coagulation Disorder
  • Cardiovascular Surgical Procedures

Sponsors & Collaborators

Principal Investigators

  • Justyna Bartoszko, MD MSc FRCPC · Toronto General Hospital - University Health Network

  • Keyvan Karkouti, MD MSc FRCPC · Toronto General Hospital - University Health Network

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-10
Primary Completion
2023-01-01
Completion
2023-01-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04762576 on ClinicalTrials.gov